TY - JOUR
T1 - Developing defined and scalable 3D culture systems for culturing human pluripotent stem cells at high densities
AU - Lei, Yuguo
AU - Jeong, Daeun
AU - Xiao, Jifang
AU - Schaffer, David V.
N1 - Funding Information:
This work was supported by California Institute of Regenerative Medicine Grant RT2-02022, a California Institute for Regenerative Medicine training grant T1-00007 fellowship (to Y. L.), and NIH 1R01ES020 903-01.
PY - 2014/6
Y1 - 2014/6
N2 - Human pluripotent stem cells (hPSCs) - including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) - are very promising candidates for cell therapies, tissue engineering, high throughput pharmacology screens, and toxicity testing. These applications require large numbers of high quality cells; however, scalable production of human pluripotent stem cells and their derivatives at a high density and under well-defined conditions has been a challenge. We recently reported a simple, efficient, fully defined, scalable, and good manufacturing practice (GMP) compatible 3D culture system based on a thermoreversible hydrogel for hPSC expansion and differentiation. Here, we describe additional design rationale and characterization of this system. For instance, we have determined that culturing hPSCs as a suspension in a liquid medium can exhibit lower volumetric yields due to cell agglomeration and possible shear force-induced cell loss. By contrast, using hydrogels as 3D scaffolds for culturing hPSCs reduces aggregation and may insulate from shear forces. Additionally, hydrogel-based 3D culture systems can support efficient hPSC expansion and differentiation at a high density if compatible with hPSC biology. Finally, there are considerable opportunities for future development to further enhance hydrogel-based 3D culture systems for producing hPSCs and their progeny.
AB - Human pluripotent stem cells (hPSCs) - including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) - are very promising candidates for cell therapies, tissue engineering, high throughput pharmacology screens, and toxicity testing. These applications require large numbers of high quality cells; however, scalable production of human pluripotent stem cells and their derivatives at a high density and under well-defined conditions has been a challenge. We recently reported a simple, efficient, fully defined, scalable, and good manufacturing practice (GMP) compatible 3D culture system based on a thermoreversible hydrogel for hPSC expansion and differentiation. Here, we describe additional design rationale and characterization of this system. For instance, we have determined that culturing hPSCs as a suspension in a liquid medium can exhibit lower volumetric yields due to cell agglomeration and possible shear force-induced cell loss. By contrast, using hydrogels as 3D scaffolds for culturing hPSCs reduces aggregation and may insulate from shear forces. Additionally, hydrogel-based 3D culture systems can support efficient hPSC expansion and differentiation at a high density if compatible with hPSC biology. Finally, there are considerable opportunities for future development to further enhance hydrogel-based 3D culture systems for producing hPSCs and their progeny.
UR - http://www.scopus.com/inward/record.url?scp=84903746950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903746950&partnerID=8YFLogxK
U2 - 10.1007/s12195-014-0333-z
DO - 10.1007/s12195-014-0333-z
M3 - Article
AN - SCOPUS:84903746950
SN - 1865-5025
VL - 7
SP - 172
EP - 183
JO - Cellular and Molecular Bioengineering
JF - Cellular and Molecular Bioengineering
IS - 2
ER -